Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study.
about
Organizing Pneumonia in Rheumatoid Arthritis Patients: A Case-Based ReviewAnti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis.Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts.Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis.Total synthesis, structural, and biological evaluation of stylissatin A and related analogs.Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.How citrullination invaded rheumatoid arthritis research.An association between amino acid position 74 of HLA-DRB1 and anti-citrullinated protein antibody levels in Japanese patients with anti-citrullinated protein antibody-positive rheumatoid arthritis.The challenge of using the rheumatoid arthritis diagnostic criteria in clinical practice.Distinct arthropathies of the hands in patients with anti-aminoacyl tRNA synthetase antibodies: usefulness of autoantibody profiles in classifying patients.Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
P2860
Q26778887-A978DF67-1320-40A9-A3FA-A095A157C605Q34586496-6261D819-812D-4762-86BB-03806B9C0250Q34746646-5EA2D031-F7E5-47DD-8146-9D3AF1AF3162Q35645491-DF425DA7-0B77-4812-BECE-A49FE29851F8Q37587406-B19990DB-0E57-4221-A9C2-C9929D875A35Q38751748-F8861AB3-6441-4221-9065-D1ECF83BECCBQ38857820-6C71A420-DFFC-4EC9-A583-916FA22A552EQ40834260-C13C187C-3170-41CF-B742-F4D0E32C7810Q41126608-289C5859-F6BE-40DE-AEA2-204334E85292Q41449014-58184563-E42B-48E5-867A-1F3846287C72Q50725161-CB28CDDE-F635-4329-84C3-E07DDBC56AFFQ55025616-18C30BBB-59E4-4C84-A793-912650486E41
P2860
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Anti-cyclic citrullinated pept ...... om a 2-year prospective study.
@en
type
label
Anti-cyclic citrullinated pept ...... om a 2-year prospective study.
@en
prefLabel
Anti-cyclic citrullinated pept ...... om a 2-year prospective study.
@en
P2093
P2860
P50
P356
P1476
Anti-cyclic citrullinated pept ...... om a 2-year prospective study.
@en
P2093
Alessia Alunno
Antonella Afeltra
Claudia Alpini
Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA Group)
Gabriella Morozzi
Giandomenico Sebastiani
Matteo Filippini
Onelia Bistoni
Paola Sabatini
Stefania Manganelli
P2860
P2888
P356
10.1186/AR4148
P577
2013-01-22T00:00:00Z
P5875
P6179
1019184131